Invention Grant
- Patent Title: PRKC fusions
-
Application No.: US16513176Application Date: 2019-07-16
-
Publication No.: US11261497B2Publication Date: 2022-03-01
- Inventor: Nicolas Stransky , Joseph L. Kim
- Applicant: BLUEPRINT MEDICINES CORPORATION
- Applicant Address: US MA Cambridge
- Assignee: BLUEPRINT MEDICINES CORPORATION
- Current Assignee: BLUEPRINT MEDICINES CORPORATION
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/04 ; C12Q1/6886 ; C07K16/30 ; C12N15/113 ; G01N33/574
Abstract:
The invention provides PRKC gene fusions, PRKC fusion proteins, and fragments of those genes and polypeptides. The invention further provides methods of diagnosing and treating diseases or disorders associated with PRKC fusions, such as conditions mediated by aberrant PRKC expression or activity, or overexpression of PRKC.
Public/Granted literature
- US20200181715A1 PRKC FUSIONS Public/Granted day:2020-06-11
Information query
